Rapport Therapeutics Stock (NASDAQ: RAPP) stock price, news, charts, stock research, profile.
Open | $23.62 |
Close | $24.27 |
Volume / Avg. | 49.60K / 350.84K |
Day Range | 23.55 - 24.90 |
52 Wk Range | 18.00 - 27.11 |
Market Cap | $858.59M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 0.72% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rapport Therapeutics (NASDAQ:RAPP) through any online brokerage.
Other companies in Rapport Therapeutics’s space includes: GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and Tarsus Pharmaceuticals (NASDAQ:TARS).
There is no analysis for Rapport Therapeutics.
Rapport Therapeutics has a consensus price target of $23.33.
The stock price for Rapport Therapeutics (NASDAQ: RAPP) is $23.88 last updated July 5, 2024 at 9:29 AM EDT.
There are no upcoming dividends for Rapport Therapeutics.
Rapport Therapeutics’s Q2 earnings are confirmed for Saturday, August 10, 2024.
There is no upcoming split for Rapport Therapeutics.
Rapport Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.